These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2029417)

  • 21. Long-term followup of a randomized study of locally advanced prostate cancer treated with combined orchiectomy and external radiotherapy versus radiotherapy alone.
    Granfors T; Modig H; Damber JE; Tomic R
    J Urol; 2006 Aug; 176(2):544-7. PubMed ID: 16813885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormonal therapy of prostate cancer: current concepts and future prospects.
    Smith JA
    Clin Ther; 1988; 10(3):281-6. PubMed ID: 3078908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine therapy for prostate cancer: recent developments and current status.
    Schröder FH
    Br J Urol; 1993 Jun; 71(6):633-40. PubMed ID: 8343887
    [No Abstract]   [Full Text] [Related]  

  • 24. Combined hormono/chemotherapy as primary treatment for metastatic prostate cancer: a randomized, multicenter study of orchiectomy alone versus orchiectomy plus estramustine phosphate. The Dutch Estracyt Study Group.
    Janknegt RA; Boon TA; van de Beek C; Grob P
    Urology; 1997 Mar; 49(3):411-20. PubMed ID: 9123707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-line treatment of metastatic prostate cancer. Androgen suppression for symptomatic disease.
    Prescrire Int; 2013 Feb; 22(135):48-51. PubMed ID: 23444510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results.
    Homma Y; Akaza H; Okada K; Yokoyama M; Moriyama N; Usami M; Hirao Y; Tsushima T; Sakamoto A; Ohashi Y; Aso Y;
    Int J Urol; 2004 May; 11(5):295-303. PubMed ID: 15147545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of combined radiation therapy and hormonal therapy in the management of lymph node-positive prostate cancer.
    Whittington R; Malkowicz SB; Machtay M; Van Arsdalen K; Barnes MM; Broderick GA; Wein AJ
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):673-80. PubMed ID: 9336149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Management of a hormone dependent cancer with endocrine therapy--prostate cancer].
    Tsukamoto S; Akaza H
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):917-26. PubMed ID: 11478140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Counseling the patient with regional metastasis of prostate cancer.
    Montie JE
    Cancer; 1993 Feb; 71(3 Suppl):1019-23. PubMed ID: 8428324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term use of combined radiation therapy and hormonal therapy in the management of stage D1 prostate cancer.
    Robnett TJ; Whittington R; Malkowicz SB; Brereton HD; Van Arsdalen K; Drach G; Wein AJ
    Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1146-51. PubMed ID: 12128114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression.
    Zincke H; Utz DC; Taylor WF
    J Urol; 1986 Jun; 135(6):1199-205. PubMed ID: 3086572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current concepts in the management of prostatic cancer.
    Schröder FH
    Am J Clin Oncol; 1988; 11 Suppl 1():S1-5. PubMed ID: 3389335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal treatment of locally advanced prostate cancer.
    Wirth MP; Hakenberg OW; Froehner M
    World J Urol; 2007 Apr; 25(2):169-76. PubMed ID: 17333200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry.
    Sadetsky N; Greene K; Cooperberg MR; Hubbard A; Carroll PR; Satariano W
    Cancer; 2011 Oct; 117(19):4406-13. PubMed ID: 21412760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy.
    Mayer FJ; Crawford ED
    Urol Clin North Am; 1994 Nov; 21(4):707-15. PubMed ID: 7974899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen deprivation prior to radical prostatectomy for T2b and T3 prostate cancer.
    Soloway MS; Hachiya T; Civantos F; Murphy WM; Gomez CC; Ruiz HE
    Urology; 1994 Feb; 43(2 Suppl):52-6. PubMed ID: 7509535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach.
    de Pinieux G; Legrier ME; Poirson-Bichat F; Courty Y; Bras-Gonçalves R; Dutrillaux AM; Némati F; Oudard S; Lidereau R; Broqua P; Junien JL; Dutrillaux B; Poupon MF
    Am J Pathol; 2001 Aug; 159(2):753-64. PubMed ID: 11485933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Theoretical considerations and initial clinical results of intermittent hormone treatment of patients with advanced prostatic carcinoma].
    Bruchovsky N; Goldenberg SL; Rennie PS; Gleave M
    Urologe A; 1995 Sep; 34(5):389-92. PubMed ID: 7483155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New methods of endocrine management of prostatic cancer.
    Smith JA
    J Urol; 1987 Jan; 137(1):1-10. PubMed ID: 3540320
    [No Abstract]   [Full Text] [Related]  

  • 40. Hormone-dependence of prostatic cancer and principles of androgen deprivation.
    Neumann F
    Arch Ital Urol Androl; 1993 Dec; 65(6):633-45. PubMed ID: 8312946
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.